Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers

Related articles

1. The delivery of nano-formulated drugs to solid tumours is selectively increased by co-application of the vascular disrupting agent CA4P

   This article has 14 authors:

   1. Annabel Kitowski
   2. Constanze Heise
   3. Stefanie Sperling
   4. Jasmin Hotz
   5. Danica Bajic
   6. Marina Rubey
   7. Kathrin Klar
   8. Georg Höfner
   9. Julien Vollaire
   10. Veronique Josserand
   11. Jean-Luc Coll
   12. Oliver Thorn-Seshold
   13. Petar Marinković
   14. Julia Thorn-Seshold

2. Actinium-225 dendrimer-radioconjugates combined with low-dose standard-of-care chemotherapy: site-independent treatment of triple negative breast cancer metastases

   This article has 9 authors:

   1. Pooja Hariharan
   2. Rajiv Nair
   3. Aira Sarkar
   4. Kathleen L. Gabrielson
   5. Tony Wu
   6. Chang Liu
   7. Wathsala Liyanage
   8. Rangaramanujam M Kannan
   9. Stavroula Sofou

3. Evaluation of RC48-ADC in combination with PRaG regimen: An open-label, prospective, multicentre study assessing efficacy and safety for advanced refractory HER2-expressing solid tumors (PRaG3.0 Study Protocol)

   This article has 9 authors:

   1. Meiling Xu
   2. Yuehong Kong
   3. Junjun Zhang
   4. Rongzheng Chen
   5. Pengfei Xing
   6. Xiangrong Zhao
   7. Shicheng Li
   8. Yingying Xu
   9. Liyuan Zhang